Tsuyoshi Konishi, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the latest in non-surgical treatment strategies for patients with rectal cancer, including accurate monitoring of clinical complete response after neoadjuvant therapy. Dr Konishi additionally highlights the need for monitoring patients post-surgery, where the risk of regrowth is high, as well as salvage surgery in patients where regrowth happens. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.